Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00800904
First received: December 1, 2008
Last updated: December 2, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- Asthma control test [ Time Frame: On the survey date ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Asthma control in mild, moderate and severe persistent asthma patients [ Time Frame: On the survey date ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1210 |
| Study Start Date: | May 2009 |
| Study Completion Date: | November 2009 |
Eligibility| Ages Eligible for Study: | 12 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patient aged 12 years and older who established persistent asthma and currently treated with any inhaled corticosteroid for 3 months or longer.
Criteria
Inclusion Criteria:
- Established persistent asthma
- Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer
Exclusion Criteria:
- Currently participating or have participated in a study with an investigational compound within the last 30 days
- Current diagnosis of chronic obstructive pulmonary disease (COPD)
- Smoked more than 10 packs a year
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00800904
Locations
| Thailand | |
| Research Site | |
| Amnat Charoen, Thailand | |
| Research Site | |
| Buriram, Thailand | |
| Research Site | |
| Chachoengsao, Thailand | |
| Research Site | |
| Chaiyaphum, Thailand | |
| Research Site | |
| Chanthaburi, Thailand | |
| Research Site | |
| Chiang Rai, Thailand | |
| Research Site | |
| Kalasin, Thailand | |
| Research Site | |
| Khon Kaen, Thailand | |
| Research Site | |
| Lopburi, Thailand | |
| Research Site | |
| Mae Hong Son, Thailand | |
| Research Site | |
| Mahasarakham, Thailand | |
| Research Site | |
| Nakhon Phanom, Thailand | |
| Research Site | |
| Nakhorn Ratchasima, Thailand | |
| Research Site | |
| Nan, Thailand | |
| Research Site | |
| Nong Khai, Thailand | |
| Research Site | |
| Samutsongkhram, Thailand | |
| Research Site | |
| Si Sa Ket, Thailand | |
| Research Site | |
| Singburi, Thailand | |
| Research Site | |
| Songkla, Thailand | |
| Research Site | |
| Sukhothai, Thailand | |
| Research Site | |
| Surat Thani, Thailand | |
| Research Site | |
| Trang, Thailand | |
| Research Site | |
| Trat, Thailand | |
| Research Site | |
| Ubon Ratchathani, Thailand | |
| Research Site | |
| Udon Thani, Thailand | |
| Research Site | |
| Yasothon, Thailand | |
Sponsors and Collaborators
AstraZeneca
Investigators
| Principal Investigator: | Bandit Thinkhamrop, PhD | Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University |
| Principal Investigator: | Watchara Boonsawat, MD. PhD | Department of Medicine, Faculty of Medicine, Khon Kaen University |
More Information
No publications provided
| Responsible Party: | Thanu Komolsai, MD, Medical Advisor, AstraZeneca (Thailand) Ltd. |
| ClinicalTrials.gov Identifier: | NCT00800904 History of Changes |
| Other Study ID Numbers: | NIS-RTH-DUM-2008/1 |
| Study First Received: | December 1, 2008 |
| Last Updated: | December 2, 2010 |
| Health Authority: | Thailand: Ethical Committee |
Keywords provided by AstraZeneca:
|
Asthma Inhaled corticosteroid Thai patient eligibility Persistent asthma |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013